Home › Therapeutic areas › Oncology › Sarcoma

Sarcoma (3 companies)

Companies with an active program in Sarcoma.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
ELTX Elicio Therapeutics Oncology 1 Phase 2 $40.5M 6
MBRX Moleculin Biotech Oncology 1 Phase 2 $7.3M 9
TLX Telix Pharmaceuticals Oncology 2 Approved $3.01B 25